|
| 36632563 | Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas. | Oncoimmunology | 2023 |
| 36189308 | Tumor necrosis factor receptor regulation of peripheral node addressin biosynthetic components in tumor endothelial cells. | Front Immunol | 2022 |
| 35537413 | An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes. | Cancer Cell | 2022 |
| 36531040 | NK cells reduce anergic T cell development in early-stage tumors by promoting myeloid cell maturation. | Front Oncol | 2022 |
| 34167064 | Phospho-β-catenin expression in primary and metastatic melanomas and in tumor-free visceral tissues, and associations with expression of PD-L1 and PD-L2. | Pathol Res Pract | 2021 |
| 33619119 | Differential Expression of CD49a and CD49b Determines Localization and Function of Tumor-Infiltrating CD8<sup>+</sup> T Cells. | Cancer Immunol Res | 2021 |
| 34454518 | Associations of immune cell homing gene signatures and infiltrates of lymphocyte subsets in human melanomas: discordance with CD163<sup>+</sup> myeloid cell infiltrates. | J Transl Med | 2021 |
| 34597591 | B cells and cancer. | Cancer Cell | 2021 |
| 34413086 | Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer Patients. | Cancer Immunol Res | 2021 |
| 31472106 | Antibiotics Drive Microbial Imbalance and Vitiligo Development in Mice. | J Invest Dermatol | 2020 |
| 33139300 | Insights into Tumor-Associated Tertiary Lymphoid Structures: Novel Targets for Antitumor Immunity and Cancer Immunotherapy. | Cancer Immunol Res | 2020 |
| 32385144 | MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma. | J Immunother Cancer | 2020 |
| 31134089 | The Antigen Processing and Presentation Machinery in Lymphatic Endothelial Cells. | Front Immunol | 2019 |
| 31425296 | The Barrier Molecules Junction Plakoglobin, Filaggrin, and Dystonin Play Roles in Melanoma Growth and Angiogenesis. | Ann Surg | 2019 |
| 31057546 | Comparative Transcriptomic Analysis Identifies a Range of Immunologically Related Functional Elaborations of Lymph Node Associated Lymphatic and Blood Endothelial Cells. | Front Immunol | 2019 |
| 31134297 | Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumors. | Cancer Immunol Immunother | 2019 |
| 29311385 | Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity. | J Immunol | 2018 |
| 30141017 | Identification and Characterization of Tertiary Lymphoid Structures in Murine Melanoma. | Methods Mol Biol | 2018 |
| 30288359 | Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanoma. | Oncoimmunology | 2018 |
| 29480817 | Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. | J Clin Invest | 2018 |
| 27550523 | Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma. | J Proteome Res | 2017 |
| 29097419 | Differential Expression of Homing Receptor Ligands on Tumor-Associated Vasculature that Control CD8 Effector T-cell Entry. | Cancer Immunol Res | 2017 |
| 28903331 | The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status. | Oncotarget | 2017 |
| 25968334 | Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. | Nat Commun | 2015 |
| 26216636 | Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment. | Adv Cancer Res | 2015 |
| 25857745 | Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. | Nat Commun | 2015 |
| 24503860 | Tolerogenic properties of lymphatic endothelial cells are controlled by the lymph node microenvironment. | PLoS One | 2014 |
| 25580369 | Regulation of T-cell Tolerance by Lymphatic Endothelial Cells. | J Clin Cell Immunol | 2014 |
| 25297629 | MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer. | Cancer Res | 2014 |
| 24935676 | Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. | Pigment Cell Melanoma Res | 2014 |
| 23597565 | Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. | Cancer Cell | 2013 |
| 24080233 | Regulatory T cells and vasectomy. | J Reprod Immunol | 2013 |
| 24048523 | MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia. | Sci Transl Med | 2013 |
| 23966998 | Peripheral tissue homing receptor control of naïve, effector, and memory CD8 T cell localization in lymphoid and non-lymphoid tissues. | Front Immunol | 2013 |
| 23926324 | Peripheral tissue homing receptors enable T cell entry into lymph nodes and affect the anatomical distribution of memory cells. | J Immunol | 2013 |
| 23060883 | Lymphatic endothelial cells - key players in regulation of tolerance and immunity. | Front Immunol | 2012 |
| 22993390 | Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. | Blood | 2012 |
| 20083666 | Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. | J Immunol | 2010 |
| 20660615 | Tumor masses support naive T cell infiltration, activation, and differentiation into effectors. | J Exp Med | 2010 |
| 20212096 | CD8 T cells activated in distinct lymphoid organs differentially express adhesion proteins and coexpress multiple chemokine receptors. | J Immunol | 2010 |
| 20109752 | Targeting allergen to FcgammaRI reveals a novel T(H)2 regulatory pathway linked to thymic stromal lymphopoietin receptor. | J Allergy Clin Immunol | 2010 |
| 20308365 | Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. | J Exp Med | 2010 |
| 20417641 | Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells. | J Mol Biol | 2010 |
| 19234124 | Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition. | Proc Natl Acad Sci U S A | 2009 |
| 19581576 | Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy. | Proc Natl Acad Sci U S A | 2009 |
| 19342661 | N-glycosylation enhances presentation of a MHC class I-restricted epitope from tyrosinase. | J Immunol | 2009 |
| 18086491 | Targeting Fel d 1 to FcgammaRI induces a novel variation of the T(H)2 response in subjects with cat allergy. | J Allergy Clin Immunol | 2008 |
| 18836451 | Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self. | Nat Immunol | 2008 |
| 19017974 | MHC class II presentation of gp100 epitopes in melanoma cells requires the function of conventional endosomes and is influenced by melanosomes. | J Immunol | 2008 |
| 18641319 | Activated CD8 T cells redistribute to antigen-free lymph nodes and exhibit effector and memory characteristics. | J Immunol | 2008 |